Medicamentos de alto riesgo para niños http://t.co/TrNHEAgz9V vía @pediamecum #SegPac
— Sano y salvo (@sanoysalvoblog) December 2, 2013
Pediatría basada en pruebas: Paracetamol y asma: ¿existe relación? http://t.co/Gx1ClC2ygq #SegPac
— Sano y salvo (@sanoysalvoblog) December 2, 2013
Homeopatía y productos dietéticos que no precisan prescripción médica: ¿son siempre inofensivos? http://t.co/d8r2J4L2CK #SegPac
— Sano y salvo (@sanoysalvoblog) December 2, 2013
When is child-resistant packaging not child resistant? http://t.co/z4hvhnZsBK #PtSafety
— Sano y salvo (@sanoysalvoblog) December 2, 2013
(Australian Prescriber) Prescripción off label (fuera de las condiciones autorizadas en la ficha técnica) http://t.co/P4oXuPeQSN
— Farmacia DA Oeste AP (@FarmaciaOesteAP) December 2, 2013
Patient-centred prescribing http://t.co/W43K1yceR1 #PtSafety
— Sano y salvo (@sanoysalvoblog) December 2, 2013
Australia Medicines Safety Update: Pioglitazone risk–benefit review http://t.co/6K7JhAFL9M #PtSafety
— Sano y salvo (@sanoysalvoblog) December 2, 2013
Australia Medicines Safety Update: 5-alpha reductase inhibitors and risk of high-grade prostate cancer - See more at: http://t.co/zDqDF1x1mT
— Sano y salvo (@sanoysalvoblog) December 2, 2013
Australia Medicines Safety Update: Duloxetine and serotonin syndrome http://t.co/6K7JhAFL9M #PtSafety
— Sano y salvo (@sanoysalvoblog) December 2, 2013
Australia Medicines Safety Update: Minocycline and intracranial hypertension http://t.co/6K7JhAFL9M #PtSafety
— Sano y salvo (@sanoysalvoblog) December 2, 2013
(No Gracias) “MUNDO ESTATINA” http://t.co/dmClM4T36f sobre las nuevas guías de la AHA y de ACC #SegPac
— Sano y salvo (@sanoysalvoblog) December 2, 2013
JAMA-More Than a Billion People Taking Statins? Potential Implications of the New Cardiovascular Guidelines http://t.co/OaFusR1Fyu #PtSafety
— Sano y salvo (@sanoysalvoblog) December 2, 2013
@sanoysalvoblog El NewEngland se apunta a la polemica, pero justificandola http://t.co/zAejYDdenj
— Antonio Ortega (@AorcarOrtega) December 3, 2013
Butlletí de Farmacovigilància de Catalunya: Febuxostat y alteraciones hepáticas http://t.co/CgkyPPmQDv #SegPac
— Sano y salvo (@sanoysalvoblog) December 3, 2013
American Family Physician: sobre las nuevas guías de uso de estatinas http://t.co/aAB78G4WwI #SegPac
— Sano y salvo (@sanoysalvoblog) December 3, 2013
Clobazan (Noiafren): FDA Drug Safety Communication - Risk of Serious Skin Reactions http://t.co/2CuZvSSudj #PtSafety
— Sano y salvo (@sanoysalvoblog) December 3, 2013
(3 clics) Ingesta de calcio y riesgo cardiovascular http://t.co/roFqYpanm3 #SegPac
— Sano y salvo (@sanoysalvoblog) December 3, 2013
The frequency of drug-related valve disease has long been underestimated [Prescrire] http://t.co/oeNWremB1s #PtSafety
— Sano y salvo (@sanoysalvoblog) December 3, 2013
#Domperidone can cause severe cardiac disorders and death: this drug should be withdrawn now [Prescrire] http://t.co/0rOyYgJzdr #PtSafety
— Sano y salvo (@sanoysalvoblog) December 3, 2013
#Domperidona (#Motilium y EFG), antiemético no mejor que placebo que puede causar arritmias y muerte, debe ser retirado (Prescrire) #SegPac
— Sano y salvo (@sanoysalvoblog) December 3, 2013
Nota de @AEMPSGOB de 2011 sobre #Domperidona (#Motilium y EFG) y riesgo cardíaco http://t.co/MgJq62tSLe #SegPac
— Sano y salvo (@sanoysalvoblog) December 3, 2013
(BMJ) Half of drug trials with results on http://t.co/oB04O6jdYr are not published in journals http://t.co/dqgUfvsNqH #PtSafety #AllTrials
— Sano y salvo (@sanoysalvoblog) December 4, 2013
"@medskep The Statin Insanity | http://t.co/yw4NZ5uawH David H. Newman, M.D.responds to the new 'guidelines' " #DiseaseMongering #PtSafety
— Sano y salvo (@sanoysalvoblog) December 4, 2013
“@c_c_baxter: “ACE inhibitor angioedema - A very late presentation” http://t.co/albxfIG23f” #PtSafety
— Sano y salvo (@sanoysalvoblog) December 4, 2013
Adverse effects of homeopathy: systematic review of published case reports and case series http://t.co/lebogUzHse vía @ojedathies #PtSafety
— Sano y salvo (@sanoysalvoblog) December 4, 2013
(Lancet) Statins: new American guidelines for prevention of cardiovascular disease http://t.co/VrpceWcmh0 #PtSafety
— Sano y salvo (@sanoysalvoblog) December 4, 2013
(AAFP) New Guidelines Propose Significant Shift in Cholesterol Management http://t.co/rR9idhto9n #PtSafety
— Sano y salvo (@sanoysalvoblog) December 4, 2013
(BMJ) Too Much Medicine: from evidence to action http://t.co/DB8oAZlAx8 #PtSafety #TooMuchMedicine
— Sano y salvo (@sanoysalvoblog) December 4, 2013
@sanoysalvoblog OJO, de facto rechaza la hipótesis lipídica. Pero también de facto aumenta la población a tratar con estatinas. Una pena.
— Juan Gérvas (@JuanGrvas) December 4, 2013
BMJ theme issue on overdiagnosis & overtreatment coincides with Preventing Overdiagnosis conference in Oxford 2014 http://t.co/HO6iILXwuD
— Ray Moynihan (@raymoynihan) December 4, 2013
Our OpEd on the new cholesterol guidelines and calculator http://t.co/fckiOxP1vV Why has nobody else mentioned patient preferences - so sad
— James McCormack (@medmyths) December 4, 2013
Multiple medications for older people can contribute to harm but steps can be taken to reduce risk - more @ http://t.co/Cn2DfftyCc #ptsafety
— Health Foundation (@HealthFdn) December 5, 2013
Read latest @TJCommission Leadership blog by EVP Ann Scott Blouin about patient and worker safety: http://t.co/6buZoVYxeG. #ptsafety
— The Joint Commission (@TJCommission) December 2, 2013
(Primum non nocere) No eres tú, soy yo: hora de reducir la brecha en la atención de fin de semana http://t.co/hQ5CLIicvQ #SegPac
— Sano y salvo (@sanoysalvoblog) December 5, 2013
Risks to patient safety associated with implementation of electronic interventions for medication management http://t.co/0KKhECfhZV
— Sano y salvo (@sanoysalvoblog) December 6, 2013
(Quid pro quo) Cuidado con el riesgo de sobredosificación de los fármacos opioides a nivel ambulatorio http://t.co/eRWEuf4OTA #SegPac
— Sano y salvo (@sanoysalvoblog) December 7, 2013
"Error médico: un fenómeno paralelo" Revisión didáctica #SegPac http://t.co/6pWrzL9jEi vía @txemacoll
— Sano y salvo (@sanoysalvoblog) December 8, 2013
*El equipo que mantiene @sanoysalvoblog está compuesto por Cecilia Calvo Pita @cecilicp y Jesús Palacio Lapuente @je_pala.
Realiza la publicación de estas selecciones Txema Coll Benejam @txemacoll.
No hay comentarios:
Publicar un comentario